Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Oct 20, 2025
24:47
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Aaron Lisberg from the University of California, Los Angeles discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer.
Lung Cancer Update